Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansseau

Showing results (231-240 of 267) with videos related to

Pageof 27
Sort By:
Skeletal Muscle|January 14, 2018
Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonucleiCéline Vanderplanck, Alexandra Tassin, Eugénie Ansseau, et al.
Psychopharmacology|February 1, 1994
Controlled comparison of milnacipran and fluoxetine in major depressionM Ansseau, P Papart, B Troisfontaines, et al.
Biological Psychiatry|August 1, 1987
Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxycorticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression testE Demey-Ponsart, M Ansseau, J Sulon, et al.
The American Journal of Psychiatry|February 1, 1994
Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter studyM Schittecatte, G Charles, R Machowski, et al.
European Addiction Research|April 3, 2015
Efficacy of Heroin-assisted Treatment In Belgium: A Randomised Controlled TrialIsabelle Demaret, Etienne Quertemont, Géraldine Litran, et al.
Acta Psychiatrica Belgica|July 1, 1992
An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patientsP Mesters, M Ansseau, R Brasseur, et al.
Human Psychopharmacology|October 31, 2002
Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*H. Lôo, J. Saiz-Ruiz, J. A. Costa E Silva, et al.
Journal of Cellular and Molecular Medicine|December 5, 2012
DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?Alexandra Tassin, Dalila Laoudj-Chenivesse, Céline Vanderplanck, et al.
Psychopharmacology|June 1, 1994
Controlled comparison of nefazodone and amitriptyline in major depressive inpatientsM Ansseau, P Darimont, A Lecoq, et al.
Journal of Affective Disorders|May 1, 1987
Age and gender effects on the diagnostic power of the DSTM Ansseau, Y Depauw, G Charles, et al.
Pageof 27

Showing results (231-240 of 267) with videos related to

Sort By:
Pageof 27
Skeletal Muscle|January 14, 2018
Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonucleiCéline Vanderplanck, Alexandra Tassin, Eugénie Ansseau, et al.
Psychopharmacology|February 1, 1994
Controlled comparison of milnacipran and fluoxetine in major depressionM Ansseau, P Papart, B Troisfontaines, et al.
Biological Psychiatry|August 1, 1987
Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxycorticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression testE Demey-Ponsart, M Ansseau, J Sulon, et al.
The American Journal of Psychiatry|February 1, 1994
Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter studyM Schittecatte, G Charles, R Machowski, et al.
European Addiction Research|April 3, 2015
Efficacy of Heroin-assisted Treatment In Belgium: A Randomised Controlled TrialIsabelle Demaret, Etienne Quertemont, Géraldine Litran, et al.
Acta Psychiatrica Belgica|July 1, 1992
An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patientsP Mesters, M Ansseau, R Brasseur, et al.
Human Psychopharmacology|October 31, 2002
Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*H. Lôo, J. Saiz-Ruiz, J. A. Costa E Silva, et al.
Journal of Cellular and Molecular Medicine|December 5, 2012
DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?Alexandra Tassin, Dalila Laoudj-Chenivesse, Céline Vanderplanck, et al.
Psychopharmacology|June 1, 1994
Controlled comparison of nefazodone and amitriptyline in major depressive inpatientsM Ansseau, P Darimont, A Lecoq, et al.
Journal of Affective Disorders|May 1, 1987
Age and gender effects on the diagnostic power of the DSTM Ansseau, Y Depauw, G Charles, et al.
Pageof 27